![](/img/cover-not-exists.png)
929O_PRICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis
Clamp, A.R., McNeish, I., Dean, A., Gallardo, D., Weon-Kim, J., O'Donnell, D., Hook, J., Coyle, C., Blagden, S.P., Brenton, J., Naik, R., Perren, T., Sundar, S., Cook, A., James, E., Swart, A.M., StenVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx440.039
Date:
September, 2017
File:
PDF, 84 KB
english, 2017